Hengrui’s PD-1 Camrelizumab Moves Step Closer To US Filing

Positive Outcomes From Supporting Multiregional Trial

Hengrui to go abroad
Hengrui comes a step closer to bringing its PD-1 contender to the US • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia